Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3701
Ideal Power
IPWR
$43.2M
| $75.8K | ﹤0.01% |
+14,146
| New | +$72K |
2026 Q2
0 quarters
|
|
3702
LENZ Therapeutics
LENZ
$95.8M
| $75.3K | ﹤0.01% |
13,256
-1,671
| -11% | -$13.5K |
2025 Q2
4 quarters
|
|
3703
So-Young International
SY
$201M
| $74.4K | ﹤0.01% |
50,277
-6,980
| -12% | -$16.8K |
2025 Q3
3 quarters
|
|
3704
Health Catalyst
HCAT
$127M
| $74.2K | ﹤0.01% |
37,278
-80,852
| -68% | -$117K |
2019 Q4
26 quarters
|
|
3705
Gossamer Bio
GOSS
$63.5M
| $72.8K | ﹤0.01% |
5,528
-284
| -5% | -$6.34K |
2025 Q1
5 quarters
|
|
3706
Cardlytics
CDLX
$10.5M
| $70.1K | ﹤0.01% |
15,617
-1,584
| -9% | -$11.8K |
2020 Q4
22 quarters
|
|
3707
DHI Group
DHX
$196M
| $68.6K | ﹤0.01% |
18,489
-2,104
| -10% | -$6.95K |
2025 Q2
4 quarters
|
|
3708
eHealth
EHTH
$15.8M
| $68K | ﹤0.01% |
45,607
-23,890
| -34% | -$40K |
2013 Q2
52 quarters
|
|
3709
AN2 Therapeutics
ANTX
$171M
| $67K | ﹤0.01% |
+13,839
| New | +$59.5K |
2026 Q2
0 quarters
|
|
3710
Stereotaxis
STXS
$86.4M
| $66.3K | ﹤0.01% |
38,570
+12,152
| +46% | +$22.8K |
2024 Q2
8 quarters
|
|
3711
Nautilus Biotechnolgy
NAUT
$348M
| $65.8K | ﹤0.01% |
+35,200
| New | +$92.9K |
2026 Q2
0 quarters
|
|
3712
Acumen Pharmaceuticals
ABOS
$15.2M
| $65.6K | ﹤0.01% |
+24,588
| New | +$60.7K |
2026 Q2
0 quarters
|
|
3713
Canton Strategic Holdings
CNTN
$155M
| $65.1K | ﹤0.01% |
+23,075
| New | +$72.9K |
2026 Q2
0 quarters
|
|
3714
Comtech Telecommunications
CMTL
$38.1M
| $64.7K | ﹤0.01% |
30,796
+17,645
| +134% | +$67.9K |
2026 Q1
1 quarter
|
|
3715
Kaltura
KLTR
$221M
| $64.6K | ﹤0.01% |
49,704
+4,631
| +10% | +$6.28K |
2023 Q2
12 quarters
|
|
3716
NN Inc
NNBR
$368M
| $62.8K | ﹤0.01% |
17,490
-1,583
| -8% | -$3.94K |
2024 Q1
9 quarters
|
|
3717
OnKure Therapeutics
OKUR
$106M
| $62.2K | ﹤0.01% |
+13,636
| New | +$58.5K |
2026 Q2
0 quarters
|
|
3718
Unicycive Therapeutics
UNCY
$104M
| $61.9K | ﹤0.01% |
+13,207
| New | +$97.4K |
2026 Q2
0 quarters
|
|
3719
Veritone
VERI
$65.9M
| $61.5K | ﹤0.01% |
+44,866
| New | +$85.7K |
2026 Q2
0 quarters
|
|
3720
Seritage Growth Properties
SRG
$92.4M
| $60.8K | ﹤0.01% |
23,106
-2,585
| -10% | -$6.8K |
2025 Q2
4 quarters
|
|
3721
ADC Therapeutics
ADCT
$195M
| $59.7K | ﹤0.01% |
55,762
+14,132
| +34% | +$41.2K |
2024 Q2
8 quarters
|
|
3722
Five Point Holdings
FPH
$301M
| $59.6K | ﹤0.01% |
+11,314
| New | +$56.7K |
2026 Q2
0 quarters
|
|
3723
XTI Aerospace
XTIA
$40.4M
| $58.9K | ﹤0.01% |
32,534
+964
| +3% | +$1.85K |
2026 Q1
1 quarter
|
|
3724
Blaize Holdings
BZAI
$28.3M
| $57.8K | ﹤0.01% |
41,880
+728
| +2% | +$1.28K |
2025 Q3
3 quarters
|
|
3725
Hyperfine
HYPR
$76.1M
| $57.4K | ﹤0.01% |
+42,535
| New | +$61.4K |
2026 Q2
0 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.